The role of S100 proteins and their receptor RAGE in pancreatic cancer
作者： Estelle Leclerc , Stefan W. Vetter
DOI: 10.1016/J.BBADIS.2015.09.022
关键词:
摘要: Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with low survival rates. Current therapeutic treatments have very poor response rates due to the high inherent chemoresistance of pancreatic-cancer cells. Recent studies suggested that receptor for advanced glycation end products (RAGE) and its S100 protein ligands play important roles in progression PDAC. We will discuss potential role proteins their receptor, RAGE, development pancreatic cancer.
core.ac.uk
elsevier.com
sci-hub.se 参考文章(50)
Nigel B. Jamieson, Simon M. Denley, Jennifer Logue, Douglas J. MacKenzie, Alan K. Foulis, Euan J. Dickson, Clem W. Imrie, Ross Carter, Colin J. McKay, Donald C. McMillan, A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma Annals of Surgical Oncology. ,vol. 18, pp. 2318- 2328 ,(2011) , 10.1245/S10434-011-1560-3
Haolin Hu, Qi Zhang, Chenfei Huang, Yi Shen, Xundi Chen, Xin Shi, Wenhao Tang, Diagnostic value of S100P for pancreatic cancer: a meta-analysis Tumor Biology. ,vol. 35, pp. 9479- 9485 ,(2014) , 10.1007/S13277-014-2461-4
Stephane R. Gross, Connie Goh Then Sin, Roger Barraclough, Philip S. Rudland, Joining S100 proteins and migration: for better or for worse, in sickness and in health Cellular and Molecular Life Sciences. ,vol. 71, pp. 1551- 1579 ,(2014) , 10.1007/S00018-013-1400-7
Emmanouil Fokas, Eric O'Neill, Alex Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna, Ruth J. Muschel, Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic. Biochimica et Biophysica Acta. ,vol. 1855, pp. 61- 82 ,(2015) , 10.1016/J.BBCAN.2014.12.001
Cathleen Haase-Kohn, Susann Wolf, Nadine Herwig, Birgit Mosch, Jens Pietzsch, Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages. Biochemical and Biophysical Research Communications. ,vol. 446, pp. 143- 148 ,(2014) , 10.1016/J.BBRC.2014.02.126
Ewelina Jurewicz, Agnieszka Góral, Anna Filipek, S100A6 is secreted from Wharton's jelly mesenchymal stem cells and interacts with integrin β1 The International Journal of Biochemistry & Cell Biology. ,vol. 55, pp. 298- 303 ,(2014) , 10.1016/J.BIOCEL.2014.09.015
Thiruvengadam Arumugam, Craig D Logsdon, None, S100P: a novel therapeutic target for cancer Amino Acids. ,vol. 41, pp. 893- 899 ,(2011) , 10.1007/S00726-010-0496-4
Cha-Eun Kim, Sun-Kyung Lim, Jin-Seok Kim, In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer Journal of Controlled Release. ,vol. 157, pp. 190- 195 ,(2012) , 10.1016/J.JCONREL.2011.09.066
Sepuru K. Mohan, Arun A. Gupta, Chin Yu, Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE) Biochemical and Biophysical Research Communications. ,vol. 434, pp. 328- 333 ,(2013) , 10.1016/J.BBRC.2013.03.049
Ming-Bing Xiao, Feng Jiang, Wen-Kai Ni, Bu-You Chen, Cui-Hua Lu, Xiao-Yan Li, Run-Zhou Ni, High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker. Medical Oncology. ,vol. 29, pp. 1886- 1891 ,(2012) , 10.1007/S12032-011-0058-Y